Droplet Squeeze Microfluidic Platform for Generating Extracellular Vesicle Hybrids for Drug Delivery
Small · 2025-09 · 21 (37)
DOI: 10.1002/smll.202503807 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small, online erschienen am 07.08.2025. Verfasst von Uday Chintapula und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA. Hauptthemen laut MEDLINE: Extracellular Vesicles, Drug Delivery Systems, Microfluidics. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, NCI NIH HHS.
Abstract (Originalsprache)
Extracellular vesicles (EVs) are emerging as versatile drug delivery systems due to their intrinsic biocompatibility and targeting capabilities. However, EV integrity and efficient drug loading challenges hinder their clinical translation. To address these limitations, hybrid systems integrating lipid nanoparticles (LNPs) with EVs have gained attention for their potential in targeted and combinatorial drug delivery. This study presents a robust microfluidic approach for the scalable generation of drug‐loaded EV‐LNP hybrids (EV hybrids). The method facilitates controlled fusion between EVs and LNPs by utilizing a droplet‐mediated squeezing mechanism. Lipid composition and microfluidic parameters are optimized for the fusion of EVs and LNPs and determined physicochemical and functional characterizations of the EV hybrids. In vitro studies demonstrate that EV hybrids exhibit enhanced targeting efficiency. Moreover, small‐molecule therapeutics are successfully encapsulated within EV hybrids, significantly improving cytotoxic efficacy against melanoma in 2D and 3D culture models compared to drug‐loaded EVs or LNPs alone. The work introduces a scalable, minimally disruptive microfluidic platform for engineering EV hybrids, offering a promising strategy to advance precision nanomedicine.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA.
- The Department of Biochemistry and Biophysics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA.
- Department of Bioengineering, University of Pennsylvania, Philadelphia, PA, 19104, USA.
- Department of Energy and Chemical Engineering, Incheon National University, 119 Academy-ro, Yeonsu-gu, Incheon, 22012, Republic of Korea.
- Department of Radiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
ORCID-Profile: Uday Chintapula, Jina Ko
Förderung
- NIGMS NIH HHS
- NCI NIH HHS
Zitieren
APA
Chintapula, U., Liu, S., Castillo, A. F. D., Lim, J., Roh, Y., Mageswaran, S. K., Zhang, X., Morales, R. T., Sellmyer, M. A., Chang, Y. W., Xu, X., & Ko, J. (2025). Droplet Squeeze Microfluidic Platform for Generating Extracellular Vesicle Hybrids for Drug Delivery. Small, 21(37). https://doi.org/10.1002/smll.202503807
Vancouver
Chintapula U, Liu S, Castillo AFD, Lim J, Roh Y, Mageswaran SK, et al. Droplet Squeeze Microfluidic Platform for Generating Extracellular Vesicle Hybrids for Drug Delivery. Small. 2025;21(37). doi:10.1002/smll.202503807
BibTeX
@article{Chintapula2025,
author = {Chintapula, Uday and Liu, Shujing and Castillo, Andres Fernandez Del and Lim, Jianhua and Roh, Yoonho and Mageswaran, Shrawan Kumar and Zhang, Xiaogang and Morales, Renee-Tyler T and Sellmyer, Mark A and Chang, Yi-Wei and Xu, Xiaowei and Ko, Jina},
title = {Droplet Squeeze Microfluidic Platform for Generating Extracellular Vesicle Hybrids for Drug Delivery},
journal = {Small},
year = {2025},
volume = {21},
number = {37},
doi = {10.1002/smll.202503807}
}
EUVIMED